Delivery Order SPE2DB24D2205-SPE2DB25FEBLE
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $5,542.08 to AmerisourceBergen Drug Corp for the supply of Orgovyx 120 mg tablets (30-count units) on August 28, 2025, with completion scheduled for September 19, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. Orgovyx is a specialized pharmaceutical used in the treatment of prostate...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,385.52 to AmerisourceBergen Drug Corp for 30 tablets of Orgovyx 120 mg on August 19, 2025, with an ultimate completion date of September 10, 2025. This competitively awarded, firm fixed-price contract involves no set-aside designation and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. Orgovyx is a prescription medication used in the treatment of prostate cancer, reflecting the...
- The U.S. Defense Logistics Agency's Medical Supply Chain awarded AmerisourceBergen Drug Corp a delivery order valued at $2,771.04 on August 13, 2025, for the supply of Orgovyx 120 mg tablets in quantities of 30. This is a firm fixed-price, non-set-aside contract with a completion date of September 4, 2025, and will be performed at the company's corporate office location in Conshohocken, Pennsylvania. Orgovyx is a prescription medication used in the treatment of prostate cancer, reflecting the...
- The Defense Logistics Agency awarded a $1,460.13 delivery order to AmerisourceBergen Drug Corp on October 22, 2025, for the supply of Orgovyx 120 mg tablets in quantities of 30 units. This firm fixed-price delivery order, which is not subject to a set-aside designation, will be performed at the contractor's facility in Conshohocken, Pennsylvania, with an ultimate completion date of November 13, 2025. Orgovyx is a prescription medication used in the treatment of prostate cancer, reflecting the...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for 30 units of Orgovyx 120 mg tablets, valued at $8,313.12, with an ultimate completion date of September 3, 2025. This competitively awarded, non-set-aside contract reflects firm fixed pricing and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. Orgovyx is a prescription medication used in the treatment of prostate cancer, demonstrating the agency's ongoing need...
- The Defense Logistics Agency awarded a delivery order valued at $4,156.56 to AmerisourceBergen Drug Corp for supply of Orgovyx 120 mg tablets (30-count units) on August 13, 2025, with completion targeted for September 4, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be performed at the vendor's facility in Conshohocken, Pennsylvania. Orgovyx is a gonadotropin-releasing hormone receptor agonist used in the treatment of advanced...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on October 31, 2025, for the supply of Orgovyx 120 mg tablets in quantities of 30 units, with a contract ceiling value of $2,771.06. This firm fixed-price delivery order is scheduled for completion by November 24, 2025, and will be performed at the contractor's facility in Conshohocken, Pennsylvania. The award was competitively procured with no set-aside designation. Orgovyx is a prescription medication used...
- The Defense Logistics Agency awarded a $1,385.52 firm fixed-price delivery order to AmerisourceBergen Drug Corp for 30 units of Orgovyx 120 mg tablets, with an ultimate completion date of May 12, 2025. This non-set-aside award was issued on April 21, 2025, with performance to be fulfilled from the vendor's Conshohocken, Pennsylvania location. Orgovyx is a prescription medication used in the treatment of prostate cancer, representing the type of specialized pharmaceutical product the Defense...
- The Defense Logistics Agency awarded a delivery order valued at $2,771.04 to AmerisourceBergen Drug Corp on July 24, 2025, for the supply of Orgovyx 120 mg tablets (30-unit packages). This is a firm fixed-price, non-set-aside contract with a completion date of August 14, 2025, and will be performed at AmerisourceBergen's facility in Conshohocken, Pennsylvania. Orgovyx is a prescription medication used in the treatment of prostate cancer, representing the type of specialized pharmaceutical...
- The Defense Logistics Agency awarded a delivery order valued at $1,385.52 to AmerisourceBergen Drug Corp for Orgovyx 120 mg tablets (quantity: 30) on June 20, 2025, with an ultimate completion date of July 14, 2025. This firm fixed price delivery order represents a non-competitive set-aside award and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. Orgovyx is a specialized pharmaceutical product used in oncology treatment, reflecting the breadth of...
- SPE2DB24D2205Indefinite Delivery Contract
- SPE2DB24D2205-SPE2DB25FEBLEDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $5,542.08 to AmerisourceBergen Drug Corp for the supply of Orgovyx 120 mg tablets (30-count bottles) on April 24, 2025, with a completion date of May 15, 2025. This firm fixed-price contract represents a non-competitive set-aside award and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. Orgovyx is a prescription medication used in the treatment of advanced prostate cancer, reflecting the Defense Logistics Agency's ongoing pharmaceutical supply requirements for military and veteran healthcare systems. This delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract with DLA Troop Support Medical (designated SPE2DX), a $999,999,999.00 comprehensive pharmaceutical supply agreement extending through December 2026. As one of the nation's largest pharmaceutical distributors, AmerisourceBergen Drug Corp maintains a significant federal contract portfolio with the Defense Logistics Agency and Defense Health Agency, supplying specialty medications, brand-name and generic drugs, and medical supplies to support military healthcare operations globally. The company's track record demonstrates consistent capability to fulfill federal medical procurement requirements through competitive processes and flexible contract vehicles designed to support military readiness and healthcare delivery.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $5.5k | 4/24/25 |